Literature DB >> 24034390

Clinical remission of Merkel cell carcinoma after treatment with imatinib.

Dagmara Ewa Loader1, Robert Feldmann, Magdalena Baumgartner, Friedrich Breier, David Schrama, Jürgen Christian Becker, Andreas Steiner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24034390     DOI： 10.1016/j.jaad.2013.03.042

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  11 in total

Review 1.  Merkel cell carcinoma: Epidemiology, pathogenesis, diagnosis and therapy.

Authors:  Teresa Amaral; Ulrike Leiter; Claus Garbe
Journal:  Rev Endocr Metab Disord       Date:  2017-12       Impact factor: 6.514

Review 2.  Epidemiology, biology and therapy of Merkel cell carcinoma: conclusions from the EU project IMMOMEC.

Authors:  Jürgen C Becker; Andreas Stang; Axel Zur Hausen; Nicole Fischer; James A DeCaprio; Richard W Tothill; Rikke Lyngaa; Ulla Kring Hansen; Cathrin Ritter; Paul Nghiem; Christopher K Bichakjian; Selma Ugurel; David Schrama
Journal:  Cancer Immunol Immunother       Date:  2017-11-30       Impact factor: 6.968

3.  Merkel cell carcinoma of the lower leg with retroperitoneal GIST: a very rare association.

Authors:  Uwe Wollina; Gesina Hansel; Felicitas Zimmermann; Jacqueline Schönlebe; Andreas Nowak
Journal:  Wien Klin Wochenschr       Date:  2015-05-06       Impact factor: 1.704

4.  [Merkel cell carcinoma].

Authors:  F Kleffner; J Schürholz; S Burckhardt; C Mauch; M Schlaak
Journal:  Hautarzt       Date:  2014-09       Impact factor: 0.751

Review 5.  Merkel Cell Carcinoma Therapeutic Update.

Authors:  Nicole M Cassler; Dean Merrill; Christopher K Bichakjian; Isaac Brownell
Journal:  Curr Treat Options Oncol       Date:  2016-07

6.  Systemic Therapy for Merkel Cell Carcinoma: What's on the Horizon?

Authors:  Guilherme Rabinowits
Journal:  Cancers (Basel)       Date:  2014-05-16       Impact factor: 6.639

7.  Dramatic response of an inoperable Merkel cell carcinoma with imatinib.

Authors:  Cecile Frenard; Lucie Peuvrel; Anabelle Brocard; Melanie Saint-Jean; Anne Moreau; Brigitte Dreno; Gaelle Quéreux
Journal:  JAAD Case Rep       Date:  2016-01-09

8.  Genomic portfolio of Merkel cell carcinoma as determined by comprehensive genomic profiling: implications for targeted therapeutics.

Authors:  Philip R Cohen; Brett N Tomson; Sheryl K Elkin; Erica Marchlik; Jennifer L Carter; Razelle Kurzrock
Journal:  Oncotarget       Date:  2016-04-26

9.  Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell Carcinoma.

Authors:  Jae Eun Choi; Monique E Verhaegen; Sahr Yazdani; Rohit Malik; Paul W Harms; Doris Mangelberger; Jean Tien; Xuhong Cao; Yuping Wang; Marcin Cieślik; Jonathan Gurkan; Mishaal Yazdani; Xiaojun Jing; Kristin Juckette; Fengyun Su; Rui Wang; Bing Zhou; Ingrid J Apel; Shaomeng Wang; Andrzej A Dlugosz; Arul M Chinnaiyan
Journal:  Neoplasia       Date:  2019-02-21       Impact factor: 5.715

Review 10.  Merkel Cell Carcinoma: Epidemiology, Target, and Therapy.

Authors:  Mathew P Hughes; Matthew E Hardee; Lynn A Cornelius; Laura F Hutchins; Jurgen C Becker; Ling Gao
Journal:  Curr Dermatol Rep       Date:  2014-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.